Home » Topics » BioWorld Science

BioWorld Science
RSS

PD-145709: New tyrosine kinase inhibitor from Warner-Lambert

April 5, 1996

SU-101 designated orphan drug

April 5, 1996

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Protein kinase C modulators in the pipeline at Procyon

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

MAbs for treatment of melanoma

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

PPI-149 selected for development

April 5, 1996

Sparta develops new formulations of taxanes

April 5, 1996

Roussel Morishita reports new aromatase inhibitor

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...